Clinical Trials Browser

Phase 1 × OTHER × Parkinson Disease 4, Autosomal Dominant Lewy Body × Clear all

NCT02983006 2021-10-18

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Phase 1 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT03545815 2020-08-10

Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.

Phase 1 Unknown

Parkinson Disease 4, Autosomal Dominant Lewy Body